950691-52-8 Usage
Uses
Used in Organic Synthesis:
6-Chloro-3-fluoronicotinaldehyde is used as a key intermediate in organic synthesis for its unique reactivity and structural features. It facilitates the creation of complex organic molecules, contributing to the advancement of chemical research and development.
Used in Pharmaceutical Industry:
6-Chloro-3-fluoronicotinaldehyde is utilized as a building block in the preparation of various pharmaceutical compounds. Its potential applications in this field highlight its importance in drug discovery and development, particularly for the synthesis of novel therapeutic agents.
Used in Agrochemicals:
In the agrochemical industry, 6-Chloro-3-fluoronicotinaldehyde is employed for the synthesis of active ingredients in pesticides and other agricultural chemicals. Its unique properties allow for the development of more effective and targeted agrochemical products.
Used in Materials Science:
6-Chloro-3-fluoronicotinaldehyde also finds applications in materials science, where it is used to develop new materials with specific properties. Its contribution to this field aids in the creation of innovative materials for various applications, including electronics, coatings, and more.
Check Digit Verification of cas no
The CAS Registry Mumber 950691-52-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,0,6,9 and 1 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 950691-52:
(8*9)+(7*5)+(6*0)+(5*6)+(4*9)+(3*1)+(2*5)+(1*2)=188
188 % 10 = 8
So 950691-52-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H3ClFNO/c7-6-5(8)1-4(3-10)2-9-6/h1-3H
950691-52-8Relevant academic research and scientific papers
GPR139 RECEPTOR MODULATORS
-
Page/Page column 101, (2021/06/26)
Compounds are provided that modulate the GPR139 receptor, compositions containing the same, and to methods of their preparation and use for treatment of a malcondition wherein modulation of the GPR139 receptor is medically indicated or beneficial. Such compounds have the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein R1, R4, R5, R9, R10, Q6, Q7, and Q12 are as defined herein.
GPR139 RECEPTOR MODULATORS
-
Page/Page column 208-209, (2020/06/01)
Compounds are provided that modulate the GPR139 receptor, compositions containing the same, and to methods of their preparation and use for treatment of a malcondition wherein modulation of the GPR139 receptor is medically indicated or beneficial. Such compounds have the structure of Formula (X) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein R1, R2, R3, R4, R9, R10, R11, and R12, Q5, Q6, Q7 and Q8 are as defined herein.
ISOXAZOLIDINE DERIVED INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE 1 (RIPK 1)
-
Page/Page column 99; 163; 164, (2017/07/18)
The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.
